InDevR (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- September 12, 2019
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $7,000,000
Company Info
- Traction
- InDevR has a strong history of non-dilutive funding raises, including a $14.7M BARDA contract and recent investment from the Bill & Melinda Gates Foundation.
- Organizations Involved
- Bill & Melinda Gates Foundation
- Founders
- Dr. Kathy Rowlen
- Company Description
- InDevR is a biotechnology company poised to significantly impact vaccine process optimization and manufacturing with powerful new protein characterization tools. The company has launched several successful life science tool-based product lines including VaxArray and Cypher One.
- Market
- Vaccine process optimization and manufacturing
- Location
- Boulder, Colorado, USA
- Coinvestors
- Adjuvant Capital